GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Shiller PE Ratio

Hisamitsu Pharmaceutical Co (TSE:4530) Shiller PE Ratio : 18.23 (As of May. 03, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-03), Hisamitsu Pharmaceutical Co's current share price is 円3740.00. Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Nov. 2023 was 円205.17. Hisamitsu Pharmaceutical Co's Shiller PE Ratio for today is 18.23.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4530' s Shiller PE Ratio Range Over the Past 10 Years
Min: 15.52   Med: 21.65   Max: 35.88
Current: 18.42

During the past years, Hisamitsu Pharmaceutical Co's highest Shiller PE Ratio was 35.88. The lowest was 15.52. And the median was 21.65.

TSE:4530's Shiller PE Ratio is ranked better than
66.6% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.95 vs TSE:4530: 18.42

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2023 was 円48.250. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円205.17 for the trailing ten years ended in Nov. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hisamitsu Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Shiller PE Ratio Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.53 30.16 17.33 18.30 -

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.30 17.39 24.04 22.51 -

Competitive Comparison of Hisamitsu Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Shiller PE Ratio falls into.



Hisamitsu Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hisamitsu Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3740.00/205.17
=18.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Nov. 2023 is calculated as:

For example, Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2023 (Change)*Current CPI (Nov. 2023)
=48.25/106.9000*106.9000
=48.250

Current CPI (Nov. 2023) = 106.9000.

Hisamitsu Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201402 25.310 95.500 28.331
201405 46.680 98.100 50.867
201408 65.080 98.300 70.774
201411 57.220 97.900 62.480
201502 50.288 97.600 55.080
201505 41.270 98.700 44.699
201508 68.180 98.400 74.070
201511 70.040 98.100 76.323
201602 29.270 97.800 31.993
201605 53.480 98.200 58.218
201608 55.940 97.900 61.083
201611 106.700 98.600 115.682
201702 25.030 98.100 27.275
201705 43.890 98.600 47.585
201708 68.230 98.500 74.049
201711 77.070 99.100 83.136
201802 39.160 99.500 42.072
201805 41.230 99.300 44.386
201808 68.130 99.800 72.977
201811 49.840 100.000 53.279
201902 70.660 99.700 75.763
201905 23.130 100.000 24.726
201908 68.140 100.000 72.842
201911 95.870 100.500 101.975
202002 40.160 100.300 42.803
202005 1.390 100.100 1.484
202008 43.770 100.100 46.743
202011 24.810 99.500 26.655
202102 43.140 99.800 46.209
202105 28.890 99.400 31.070
202108 32.270 99.700 34.600
202111 14.930 100.100 15.944
202202 42.750 100.700 45.382
202205 20.450 101.800 21.475
202208 61.060 102.700 63.557
202211 37.850 103.900 38.943
202302 28.520 104.000 29.315
202305 52.050 105.100 52.941
202308 56.180 105.900 56.711
202311 48.250 106.900 48.250

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hisamitsu Pharmaceutical Co  (TSE:4530) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hisamitsu Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines